Linear plasmid lp54 is one of the most highly conserved and differentially expressed elements of the segmented genome of the Lyme disease spirochete Borrelia burgdorferi. We previously reported that deletion of a 4.1-kb region of lp54 (bba01 to bba07 [bba01-bba07]) led to a slight attenuation of tick-transmitted infection in mice following challenge with a large number of infected ticks. In the current study, we reduced the number of ticks in the challenge to more closely mimic the natural dose and found a profound defect in tick-transmitted infection of the bba01-bba07 mutant relative to wild-type B. burgdorferi. We next focused on deletion of bba03 as the most likely cause of this mutant phenotype, as previous studies have shown that expression of bba03 is increased by culture conditions that simulate tick feeding. Consistent with this hypothesis, we demonstrated increased expression of bba03 by spirochetes in fed relative to unfed ticks. We also observed that a bba03 deletion mutant, although fully competent by itself, did not efficiently infect mice when transmitted by ticks that were simultaneously coinfected with wild-type B. burgdorferi. These results suggest that BBA03 provides a competitive advantage to spirochetes carrying this protein during tick transmission to a mammalian host in the natural infectious cycle.
T he genome of Borrelia burgdorferi, the causative agent of Lyme disease, consists of a linear chromosome and numerous linear and circular plasmids (9, 15) . Several of these extrachromosomal plasmids have been shown to carry genes that are critical for B. burgdorferi viability during the infectious cycle, as it must adapt to two very different environments, i.e., the Ixodes tick vector and a mammalian host (18, 25, 38, 39, 57) . One of the most highly conserved plasmids, which also has one of the largest proportions of differentially regulated genes in the B. burgdorferi genome, is the linear plasmid lp54 (7, 10, 21, 30, 32, 39, 40, 44, 51, 52, 56) . Although several genes on lp54 have been identified as contributing to (5, 14, 41, 48) or essential for (3, 39, 58) spirochete fitness in vivo, the majority of the proteins encoded on this plasmid are of unknown function and lack homologs in other organisms (9, 15) . We previously used the Cre-lox system to delete the genes encompassing a 4.1-kb region of lp54, from bba01 to bba07 (bba01-bba07 region) (A3⌬A1-7 mutant) (4) . In addition to a delay in colony formation and distinct colony morphology, a slight defect was observed in the ability of the A3⌬A1-7 mutant to establish mammalian infection by tick bite in a challenge with 20 infected nymphs per mouse. In this study, to create a more biologically relevant model, we reduced the tick challenge to 3 ticks per mouse and found that the A3⌬A1-7 mutant was significantly attenuated in the ability to infect mice by tick bite in this challenge, whereas wild-type (WT) B. burgdorferi could routinely establish mammalian infection at a dose as low as 1 tick per mouse.
Since all attempts to complement the full A3⌬A1-7 mutant were unsuccessful, we targeted the gene within the bba01-bba07 region that was most likely responsible for this phenotype. Previous studies have shown that the putative outer membrane protein BBA03 is synthesized at higher levels under in vitro growth conditions at pH 7 than at pH 8 (8) . Because this pH shift presumably mimics the environmental changes that B. burgdorferi experiences when the tick begins taking a blood meal, the results suggested that BBA03 might play a role in B. burgdorferi transmission from the tick vector to the mammalian host. Therefore, a bba03 mutant and an isogenic complemented strain were generated in an infectious B31 background and used to investigate the requirement for the bba03 gene product during the mouse-tick infectious cycle.
MATERIALS AND METHODS
Bacterial strains and culture conditions. B. burgdorferi strains used in this study are described in Table 1 . Spirochetes were grown in BarbourStoenner-Kelly II (BSKII) medium supplemented with 6% rabbit serum (Pel Freez Biologicals, Rogers, AZ) at 35°C or on solid BSK medium incubated at 35°C under 2.5% CO 2 . DNA manipulations in Escherichia coli were performed with TOP10 cells (Invitrogen, Carlsbad, CA). Expression of BBA03 in E. coli was done in BL21(DE3)pLysS cells (Novagen, Madison, WI).
Isolation of RNA from infected ticks. Ixodes scapularis nymphs infected with wild-type B. burgdorferi were pooled into groups of five ticks and snap-frozen in liquid nitrogen either before feeding, immediately after feeding to repletion, or at 1 week postfeeding. Frozen ticks were ground with a pestle in RNase-free microcentrifuge tubes, and RNA was isolated using a Nucleospin RNA II kit (Clontech, Inc., Mountain View, CA).
qRT-PCR analysis. RNAs isolated from ticks were converted into cDNAs by use of a High-Capacity cDNA reverse transcription (RT) kit (Applied Biosystems, Carlsbad, CA) according to the manufacturer's rec-ommendations. cDNA was diluted 1:10, and 1 l was then used for each quantitative PCR (qPCR). Standard curves generated with genomic DNA from a known number of spirochetes were used to calculate the number of copies of bba03 transcript relative to the flaB transcript in fed versus unfed ticks using primers 11 and 12 and primers 13 and 14, with probes 15 and 16 (Table 2) , respectively. PCR parameters consisted of an initial cycle of 50°C for 2 min and 95°C for 10 min followed by 40 cycles consisting of 95°C for 15 s and 60°C for 1 min. All samples were run in triplicate.
Salivary gland migration studies. Migration of B. burgdorferi from the tick midgut to the salivary glands during the blood meal was investigated in both individually infected ticks (WT versus A3⌬A1-7 mutant) and coinfected ticks (WT plus ⌬A03 mutant) by feeding infected I. scapularis nymphs on mice for 72 h, removing the partially fed nymphs with forceps, and dissecting out the salivary glands and midguts. The salivary glands were washed five times in phosphate-buffered saline (PBS) plus 5 mM MgCl 2 (PBS plus MgCl 2 ) and plated on solid BSKII medium to enumerate the number of spirochetes that had migrated to the salivary glands at this time point. The midgut from each tick was also plated on appropriate antibiotic selection medium to confirm that the ticks were infected and to enumerate WT and ⌬A03 mutant spirochetes. Salivary glands were also prepared for confocal microscopy by incubating the salivary glands at 37°C for 30 min with B. burgdorferi rabbit antiserum diluted 1:100 in PBS plus bovine serum albumin (BSA), followed by coincubation at 37°C for 30 min with DRAQ5 DNA stain and fluorescein-labeled goat anti-rabbit serum diluted 1:100 in PBS plus BSA. Slides were briefly washed in PBS, and salivary glands were visualized by confocal microscopy to enumerate the number of spirochetes within the salivary glands in the WT-infected nymphs versus the A3⌬A1-7 mutant-infected ticks.
Generation of infectious ⌬bbe02 strain. B31-A3⌬bbe02 is an infectious clone that has been described previously (43) . Briefly, the bbe02 locus on lp25 of the infectious strain B31-A3 (13a) was inactivated by deletion of the 1,250-bp gene and insertion of a kanamycin resistance cassette, using the allelic exchange construct pNP (22) . Total plasmid profile screens were performed as previously described (39) to confirm that this mutant retained all B31-A3-associated plasmids. This strain has been designated B31-K10.
Suicide vector construction. The pABA03 allelic exchange construct used to delete bba03 (nucleotides 1398 to 1906 of lp54) was constructed as follows. The region of lp54 encompassing nucleotides 897 to 1397 was amplified with Taq polymerase (New England BioLabs, Ipswich, MA) from B31-A3 genomic DNA by use of primers 1 and 2 ( Table 2 ) and then cloned into pCR-XL-TOPO (Invitrogen), yielding pCR-XL-TOPO/897-1397. A KpnI site was engineered into the 5= end of primer 1, allowing removal of the native, upstream EcoRI site in pCR-XL-TOPO/897-1397 by digestion with KpnI and religation. The flaBp-driven streptomycin resistance cassette aadA was amplified from the pABA07 suicide vector (4) by use of Taq polymerase and primers 3 and 4 ( Table 2 ) and then cloned into pCR-2.1 (Invitrogen). The flaBp-aadA fragment was digested from pCR2.1 by use of the vector EcoRI sites and then ligated into the downstream EcoRI site in pCR-XL-TOPO/897-1397, yielding pCR-XL-TOPO/ 897-1397/flaBp-aadA. The lp54 region at nucleotides 1907 to 2406 was amplified from B31-A3 by use of Taq polymerase and primers 5 and 6 (Table 2 ) and then ligated into pCR-XL-TOPO/897-1397/flaBp-aadA by use of the engineered SacI site and the native PstI site, yielding pABA03.
Shuttle vector construction. The pBSV2G-A03 shuttle vector, used to complement the ⌬A03 mutant, was constructed as follows. The region of lp54 from nucleotides 1126 to 1970, which encompasses bba02 and bba03, was amplified with Taq polymerase and primers 7 and 8 (Table 2 ) and then ligated into KpnI/PstI-digested pBSV2G (13), yielding pBSV2G-A03.
B. burgdorferi transformations. Strain K10 was transformed with 20 g of the bba03 allelic exchange construct pABA03 under standard electroporation conditions (45) and then immediately resuspended in 5 ml BSKII liquid medium and allowed to recover for 24 h at 35°C. Cells were then plated on solid BSKII medium containing 50 g/ml streptomycin and incubated at 35°C. True transformants were identified by PCR screening of colonies for the loss of bba03 and the presence of the streptomycin resistance cassette aadA. Positive colonies were grown in liquid medium, and immunoblots were performed with the protein lysates, using BBA03 antiserum to confirm the loss of BBA03 protein expression. A ⌬A03 mutant was then transformed with 20 g of pBSV2G-A03, and transformants were selected on solid BSKII medium containing 40 g/ml gentamicin at 35°C. Colonies positive by PCR for the gentamicin resistance cassette aacCI were grown in 5 ml BSKII, and total genomic DNA was isolated to rescue and confirm the sequence of the complementing plasmid. Immunoblots using BBA03 antiserum were also made with lysates from the ⌬A03/A03 complemented strain to confirm that expression of BBA03 had been restored. Total plasmid profile screens were performed as previously described (39) to confirm that the ⌬A03 mutant and complemented strain had retained all wild-type-associated plasmids.
In vitro competitive growth analysis. Wild-type and ⌬A03 mutant strains were inoculated from frozen stocks, grown to mid-log phase, diluted and mixed in triplicate cultures to a total concentration of 2 ϫ 10 5 spirochetes/ml (10 5 spirochetes/ml for each strain) in 5 ml BSKII medium, and incubated at 35°C. To assess the growth rate of each strain, cultures were counted at 24-h intervals in Petroff-Hauser chambers and plated in duplicate in solid BSK medium containing either no antibiotic or 50 g/ml streptomycin in order to determine the ratio of WT to ⌬A03 mutant spirochetes at each time point.
Mouse infection studies. Mouse studies were carried out in accordance with the guidelines of the National Institutes of Health. All infection studies were done according to protocols approved by the Rocky Mountain Laboratories Animal Care and Use Committee. These studies were done using 6-to 8-week-old female RML mice, an outbred strain of SwissWebster mice reared at the Rocky Mountain Laboratories breeding facility. For standard infection studies, mice were inoculated intradermally with 5 ϫ 10 3 B. burgdorferi organisms. Mice were subsequently bled at 3 weeks postinjection to assess seroreactivity to B. burgdorferi proteins by immunoblotting. Tissues were taken from seropositive mice, placed into BSKII medium, and incubated at 35°C to confirm infection by reisolation of spirochetes.
Infectious dose studies with in vitro-grown spirochetes were done by inoculating 5 mice per dose with 10 2 , 10 3 , 10 4 , or 10 5 B. burgdorferi organisms by either intraperitoneal (i.p.)-subcutaneous (s.c.) injection (80% i.p.-20% s.c.) or intradermal (i.d.) injection. Infectious dose studies with in vivo-grown spirochetes were done by feeding infected I. scapularis nymphs on mice for 72 h, detaching them from the mice with forceps, pooling seven partially infected ticks, and grinding them in 0.7 ml BSK-H. One hundred microliters of the resulting tick homogenate was injected intradermally into each of five mice per strain. The remaining ϳ200 l was used to make serial dilutions of the tick homogenates for subsequent doses and also plated to determine the number of viable spirochetes in each serial inoculum. The resulting inocula were determined to be 1,800, 165, 10, and 0 spirochetes per mouse for wild-type B. burgdorferi and 4,500, 450, 85, 5, and 0 spirochetes per mouse for the A3⌬A1-7 mutant. Mice were bled to assess seroconversion and euthanized for culture of tissues for reisolation of spirochetes at 3 weeks postinjection. Fifty percent infectious dose (ID 50 ) values were calculated following the method of Reed and Muench (42) .
Coinfection studies using needle-inoculated in vitro-grown spirochetes were initiated by growing B. burgdorferi strains from frozen stocks to mid-log phase (approximately 5 ϫ 10 7 spirochetes/ml), diluting and mixing the strains to a combined concentration of 5 ϫ 10 4 spirochetes/ml (2.5 ϫ 10 4 spirochetes/ml for each strain), and intradermally injecting 100 l of the mixed inoculum into each mouse, resulting in a combined inoculum of 5 ϫ 10 3 B. burgdorferi spirochetes (2.5 ϫ 10 3 spirochetes of each strain) per mouse.
Analysis of B. burgdorferi infection in mice by immunoblotting. B. burgdorferi protein lysates were run in 12.5% SDS-PAGE gels, using lysates of approximately 10 7 spirochetes per well. Proteins were transferred to a nitrocellulose membrane that was then cut into strips containing individual lanes of protein lysate. Membrane strips were blocked for 1 h in 5% milk in Tris-buffered saline containing 0.1% Tween 20 (TBS-Tween) and then incubated for 1 h at room temperature with mouse serum di- Tick studies. Naturally infected ticks were obtained by feeding approximately 100 naïve I. scapularis larvae (Oklahoma State University) on each infected mouse. Some fed larvae were ground and plated in solid BSKII medium at 7 days postfeeding to assess acquisition of B. burgdorferi from infected mice. Remaining fed I. scapularis larvae were allowed to molt to nymphs and recover (approximately 12 weeks post-larval feeding) before feeding on naïve mice to assess persistence of the ⌬A03 mutant in ticks and its transmission to mice at a challenge dose of 3 ticks per mouse. Artificial infection of I. scapularis was done following the protocol established by Policastro and Schwan (37) . Briefly, B. burgdorferi was grown to approximately 1 ϫ 10 8 spirochetes/ml, and 1 ml of this culture was added to a screw-cap microcentrifuge tube containing 100 to 200 larval I. scapularis ticks that had been partially dehydrated by incubation in a bell jar for 48 h at a relative humidity of 85%. The ticks were incubated in the B. burgdorferi culture for 45 min at 35°C, washed twice with PBS, and then allowed to recover for 24 to 48 h before feeding on mice. Artificially infected larval ticks were then fed to repletion, allowed to molt to nymphs, and fed as described above. Coinfected ticks were obtained by artificially infecting larval ticks by use of an immersion inoculum containing an equal mixture of WT and ⌬A03 mutant B. burgdorferi spirochetes or WT and complemented ⌬A03/A03 spirochetes at a combined concentration of 1 ϫ 10 8 spirochetes/ml. Ticks were subsequently fed to repletion on naïve mice, and a few ticks were plated at 7 days postfeeding, using selection with the appropriate antibiotic, to confirm that they were initially infected with comparable numbers of spirochetes of each strain. The coinfected larval ticks were allowed to molt to nymphs and to feed at a challenge dose of 5 ticks per mouse to assess the transmission efficiency of the ⌬A03 mutant in the presence of wild-type spirochetes. Since both the WT and ⌬A03 mutant strains are Kan r , but only the ⌬A03 mutant is Strep r , enumeration of each specific strain present within a tick was determined by plating equal portions of each tick homogenate on solid BSK medium containing either kanamycin at 200 g/ml or streptomycin at 50 g/ml. Thus, the colonies formed under kanamycin selection represented the total number of spirochetes (WT and ⌬A03 mutant) within each tick, whereas the colonies present with streptomycin selection represented only the ⌬A03 mutant spirochetes.
BBA03 expression vector construction. The pET28a-A03 expression vector, used to overexpress bba03 in E. coli, was constructed as follows. An ExPASy proteomics server (Swiss Institute of Bioinformatics, Switzerland) hydrophobicity plot was used to predict the lipidated portion of BBA03. Based on this prediction, primer 9 was designed to remove residues 2 to 18 of the protein signal sequence. This truncated bba03 gene was amplified by use of Taq polymerase and primers 9 and 10 ( Table 2 ) and then cloned into pET28a (Novagen) by use of the native NdeI and XhoI sites, yielding pET28a-A03.
Overexpression and purification of BBA03. The pET28a-A03 expression vector was transformed into E. coli BL21(DE3)pLysS cells expressing the T7 RNA polymerase (Novagen). Expression of BBA03 was induced by the addition of 1 mM isopropyl-␤-D-1-thiogalactopyranoside (IPTG) and subsequent incubation of cells at 37°C for 4 h. Bacteria were pelleted and lysed by resuspension in BugBuster (Novagen) and incubation for 20 min at room temperature. Insoluble proteins were pelleted, and the supernatant was applied directly to a His-Bind Quick column (Novagen) for purification of BBA03 according to the manufacturer's protocol. The eluate from the His-Bind Quick column that contained purified BBA03 was concentrated using an Amicon Ultra-15 filter column (Millipore, Billerica, MA). Purified BBA03 was run in a 12.5% SDS-PAGE gel and stained with Coomassie brilliant blue (Bio-Rad, Hercules, CA) to confirm the level of purity. Recombinant purified BBA03 was quantified using a Bio-Rad protein assay (Bio-Rad, Hercules, CA). Generation of BBA03 antisera. Polyclonal BBA03 antisera were raised in New Zealand White rabbits (Jackson Laboratory, Bar Harbor, ME) in accordance with the guidelines of the National Institutes of Health and the protocols approved by the Rocky Mountain Laboratories Animal Care and Use Committee. The Rocky Mountain Laboratories are accredited by the International Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC). Rabbits were injected with a 1-ml emulsion containing 1 mg purified BBA03 in a Sigma adjuvant system (SigmaAldrich, St. Louis, MO) as follows: 300 l intradermally (50 l at each of 6 sites), 400 l intramuscularly (200 l into each hind leg), 100 l subcutaneously (neck region), and 200 l intraperitoneally. Rabbits were given a booster at 21 days with an additional 1 mg of BBA03 and were bled 14 days later to assess antibody titers to BBA03.
Fluorescence microscopy. One milliliter of mid-log-phase B. burgdorferi culture was pelleted at 8,000 ϫ g for 10 min, washed twice with PBS plus MgCl 2 , resuspended in PBS plus MgCl 2 , and placed on a slide. For immunofluorescence assays (IFAs) utilizing B. burgdorferi with nonpermeabilized outer membranes, cells were heat fixed by passing the slide over a flame three times. IFAs utilizing permeabilized B. burgdorferi were fixed by incubating the slides in acetone for 30 min. Following fixation, slides were coincubated at 37°C for 30 min with BBA03 antiserum and FlaB monoclonal antibody diluted 1:100 in PBS plus 0.75% BSA (PBS plus BSA). Slides were washed briefly in PBS and then coincubated at 37°C for 30 min with fluorescein-labeled goat anti-rabbit (BBA03) and rhodamine-labeled goat anti-mouse (FlaB) sera diluted 1:100 in PBS plus BSA. Slides were washed briefly in PBS, and images were taken with a Nikon Eclipse 80i microscope and a Nikon Digital Sight Qi1Mc camera.
Proteinase K assay. Aliquots of wild-type B. burgdorferi at mid-log phase (approximately 5 ϫ 10 7 bacteria/ml) were pelleted at 8,000 ϫ g for 10 min, washed twice in PBS plus MgCl 2 , and resuspended with various concentrations of proteinase K (0 mg/ml, 0.04 mg/ml, 0.2 mg/ml, and 1 mg/ml) diluted in PBS plus MgCl 2 . Samples were incubated for 40 min at 37°C, pelleted at 8,000 ϫ g for 10 min, washed twice with PBS plus MgCl 2 , and resuspended in 80 l of protein sample buffer. Ten microliters of sample was run in each well of a 12.5% SDS-PAGE gel and then transferred to a nitrocellulose membrane. Membranes were incubated with BBA03 antiserum to assess whether BBA03 was degraded by proteinase K. Immunoblot analysis of OspA was performed in parallel to confirm the proteinase K susceptibility of a known outer surface lipoprotein, and FlaB (a component of periplasmic flagella) integrity was monitored as a negative control to ensure that proteinase K did not penetrate the outer membrane. To confirm the susceptibility of BBA03 to proteinase K degradation, we repeated the experiment described above using proteinase K diluted in PBS plus 0.1% Triton X-100, which results in cell lysis and exposure of all B. burgdorferi proteins to proteinase K.
Active immunization with BBA03. Groups of mice were injected subcutaneously with either 50 g of purified recombinant BBA03 suspended in the Sigma adjuvant system (Sigma-Aldrich) or PBS plus adjuvant alone (control). Mice were given a booster of an additional 50 g of purified recombinant BBA03 suspended in the Sigma adjuvant system or a PBSplus-adjuvant control at 2 weeks and again at 4 weeks. Following confirmation that all immunized mice recognized BBA03 as determined by immunoblotting, mice were challenged by feeding three I. scapularis nymphs infected with wild-type B. burgdorferi on each mouse. Recovered fed nymphs were plated to enumerate spirochetes immediately upon drop-off, and mice were bled and euthanized and their tissues cultured in liquid BSK at 3 weeks post-tick challenge to assess infection by B. burgdorferi.
RESULTS
Ability of A3⌬A1-7 mutant to infect mice by tick bite. We previously found that the A3⌬A1-7 mutant displayed a minor reduction in the ability to establish infection in mice by tick bite in a challenge with 20 infected nymphs per mouse (4). To further investigate this potential phenotype, we reduced the challenge conditions to 3 ticks per mouse to create a more biologically relevant inoculum. The spirochete load in fed ticks was determined 7 days after drop-off by plating of individual crushed ticks, and mouse infection was assessed 3 weeks after tick challenge by seroconversion and reisolation of spirochetes (Table 3 ). The average number of spirochetes per fed nymphal tick was slightly higher for the A3⌬A1-7 mutant than for the WT. However, only 1 of 11 mice became infected with the A3⌬A1-7 mutant at this dose, whereas all 8 mice challenged with WT-infected ticks became infected. These experiments suggest that a gene(s) within the bba01-bba07 region of lp54 may contribute to tick-transmitted infection of B. burgdorferi in a mammalian host.
ID 50 and salivary gland migration of the A3⌬A1-7 mutant. In an effort to identify where the infectivity defect of the A3⌬A1-7 mutant occurs, we conducted an infectious dose analysis to determine if this mutant is attenuated in the ability to infect a mammal and thus perhaps this defect is apparent during tick transmission, when presumably only a few spirochetes are transmitted. ID 50 studies were done using two different sources of spirochetes: in vitro-grown B. burgdorferi and in vivo-grown B. burgdorferi obtained from crushed, partially fed nymphal ticks. The latter were used to determine the number of in vivo "primed" B. burgdorferi spirochetes needed to establish mammalian infection by tick bite.
Inocula prepared from in vitro-grown spirochetes yielded ID 50 s of 398 spirochetes for the wild type and 177 spirochetes for the A3⌬A1-7 mutant for delivery by intradermal injection, with values of 492 for the wild type and 1,202 for the A3⌬A1-7 mutant for delivery by the i.p.-s.c. route (see Tables S1 and S2 in the supplemental material). Although the ID 50 for the A3⌬A1-7 mutant was higher with i.p.-s.c. injections than with intradermal injections, it was not significantly different from that of the wild type. In vivo-grown B. burgdorferi spirochetes obtained from partially fed nymphs were able to establish infection at a much lower dose than that for in vitro-grown spirochetes, but the difference spirochetes with mouse sera diluted 1:200. The number of mice infected by A3⌬A1-7 nymphs was significantly different from the number of mice fed on by wild-typeinfected nymphs (P ϭ 0.0001, as determined by Fisher's two-tailed exact probability test). c The ear, bladder, and tibiotarsal joint were cultured from all mice, for a total of three cultured tissues from each mouse. Mice positive for infection by serology were also positive by reisolation from all three tissues, and vice versa.
was not significantly different between strains, with ID 50 s of 7 for the wild-type and 16 for the A3⌬A1-7 mutant (see Table S3 ). These data indicate that the apparent transmission defect of the A3⌬A1-7 mutant is not due simply to an attenuated ability to infect a mammal. Partially fed I. scapularis nymphs infected with either the wild type or the A3⌬A1-7 mutant were used to investigate if mutant spirochetes are unable to migrate efficiently to the salivary glands during feeding, thus physically limiting transmission from infected ticks. Salivary glands were dissected, washed 5 times in PBS plus MgCl 2 , and either plated on solid BSK medium or used for confocal microscopy. No significant difference in the average number of spirochetes within the salivary glands was found between wild-type-and A3⌬A1-7 mutant-infected ticks by plating or confocal microscopy (data not shown), suggesting that impaired migration to the salivary glands is not the underlying cause of the A3⌬A1-7 mutant phenotype. bba03 expression during the tick blood meal. In order to further investigate the defect in tick-transmitted infection of the A3⌬A1-7 mutant, we next focused on a gene whose absence may account for the attenuated phenotype. Previous studies with in vitro-grown spirochetes by Carroll et al. indicated that bba03 is expressed at higher levels at a pH of 7 than at a pH of 8 (8) . Since this pH shift is thought to provide an environmental cue sensed by spirochetes during tick feeding, we measured bba03 expression by wild-type B. burgdorferi in infected ticks before, during, and after a blood meal. RNAs were extracted from I. scapularis nymphs that were flat or replete or at 1 week postfeeding and were analyzed by qPCR to determine the relative levels of bba03 and flaB transcripts. bba03 expression in fed ticks was Ͼ6-fold higher in replete than in unfed ticks and declined to ϳ2-fold higher at 1 week postfeeding (Fig. 1) , consistent with the anticipated expression patterns of bba03 based on previous studies (8, 23) . Induction of bba03 expression during tick feeding is also consistent with a potential contribution to transmission and the underlying defect, as this gene is missing in the A3⌬A1-7 mutant.
Targeted deletion and complementation of bba03. Following the confirmation that bba03 is upregulated by spirochetes during tick feeding, we hypothesized that this gene could play a role during tick-transmitted infection of a mammalian host. K10, an infectious B31-A3 derivative lacking the gene encoding the restriction modification enzyme BBE02 (43) , was used as the background for generating a bba03 mutant to aid in the subsequent introduction of a wild-type copy of the gene on a complementation plasmid. All references to the WT in subsequent experiments refer to the K10 clone.
The bba03 gene was deleted by replacing the entire bba03 locus with a streptomycin resistance cassette, aadA, through allelic exchange with the pABA03 suicide vector (Fig. 2A) . PCR analysis confirmed that the plasmid content of the ⌬A03 mutant was identical to that of the infectious parental clone K10. Deletion of bba03 was confirmed by PCR analysis of DNA (data not shown) and by immunoblot assay of cell lysates, using BBA03 antiserum (Fig. 3) . As observed with A3⌬A1-7, the ⌬A03 mutant exhibited a more diffuse colony morphology, as well as a 2-to 3-day lag in colony formation, than that of the K10 parental clone. Complementation of the ⌬A03 mutant was achieved by reintroduction of the wildtype bba03 gene on a shuttle vector (pBSV2G-A03) (Fig. 2B) , yielding the ⌬A03/A03 strain. Complementation restored both wild-type colony growth and morphology (data not shown) and expression of BBA03 (Fig. 3) .
Although no significant in vitro growth defect was expected with the ⌬A03 mutant, as none was observed with the A3⌬A1-7 mutant, we conducted a competitive growth curve experiment to investigate if BBA03 might provide a selective advantage during in vitro growth in a mixed culture. Wild-type and ⌬A03 mutant spirochetes were combined in liquid medium at equal concentrations and plated every 24 h on solid medium, with and without streptomycin selection, to determine the number of WT versus ⌬A03 mutant spirochetes. No significant difference was found between growth rates or maximum densities achieved by the strains (data not shown).
Requirement for BBA03 in tick-transmitted mammalian infection. Mice were injected with an inoculum of 5 ϫ 10 3 spirochetes of the WT, the ⌬A03 mutant, or the ⌬A03/A03 complemented strain. B. burgdorferi infection was confirmed by seroconversion against B. burgdorferi proteins and by reisolation from ear punch biopsy specimens. Naïve larval ticks were fed to repletion on the infected mice, and a few were plated on solid BSKII medium to confirm the acquisition of spirochetes from the infected mice. Spirochete levels in ticks that fed upon WT-and ⌬A03 mutant-infected mice were found to be comparable (data not shown), suggesting that the ⌬A03 mutant colonized mouse tissues at densities similar to that of the WT. However, the complementing plasmid carrying bba03 (pBSV2G-A03) was found to have been lost from the ⌬A03/A03 strain, as none of the resulting B. burgdorferi colonies from the larval ticks retained the shuttle vector. Since the loss of pBSV2G-A03 appeared to have occurred during persistent infection of the mouse, we artificially infected naïve larvae with the WT, ⌬A03 mutant, and ⌬A03/A03 complemented strains in order to assess the contribution of BBA03 to tick-transmitted infection at the nymphal stage. The artificially infected larvae were fed to repletion, and a few ticks infected with ⌬A03/A03 were subsequently plated to assess the presence of the pBSV2G-A03 plasmid. Of the resulting colonies, 86% were found to contain pBSV2G-A03, which was considered a sufficient rate of infected ticks were fed to repletion, pooled into groups of five ticks, and snapfrozen immediately upon drop-off or at 1 week postfeeding. RNAs were isolated from the frozen fed ticks and unfed ticks, converted to cDNAs, and used to quantify copies of the bba03 transcript relative to copies of the flaB transcript. *, the means of bba03 transcript relative to flaB transcript are significantly different between fed and unfed tick-derived spirochetes, as determined by the two-tailed unpaired t test (P ϭ 0.0003).
plasmid retention to proceed with subsequent experiments. The remaining infected larvae were allowed to molt to nymphs and recover (about 3 months), and naïve mice were challenged at a dose of three ticks per mouse to test the ability of the ⌬A03 mutant to be transmitted and establish infection by this route. Both the naturally and artificially infected nymphs were used to investigate the requirement of BBA03 at this stage. At 3 weeks postfeeding, mice were bled and euthanized and their tissues cultured for reisolation of spirochetes. Seven of 10 mice that were fed on by naturally infected ⌬A03 mutant nymphs were found to be infected, and 6 of 6 mice were infected when they were fed on by WT-infected nymphs (Table 4) . Similarly, transmission studies with the artificially infected nymphs showed that 3 of 3 mice were infected when fed on by ⌬A03 mutant-infected nymphs, 2 of 2 mice were infected when fed on by WT-infected nymphs, and 2 of 3 mice were infected when fed on by ⌬A03/A03 mutant-infected nymphs (Table 5) . Interestingly, the complementing pBSV2G-A03 plasmid was again lost, but only after the nymphs had fed, as Ͼ80% of colonies screened from unfed ⌬A03/A03-infected nymphs still contained the plasmid, whereas none of the colonies derived from fed nymphs retained it. The above results indicate that BBA03 is not required by B. burgdorferi for establishing mammalian infection by tick bite and is therefore not exclusively responsible for the phenotype seen with the A3⌬A1-7 mutant.
Competitive advantage of wild type over ⌬A03 mutant during tick transmission. Although the above results suggest that BBA03 is dispensable during the infectious cycle, we investigated whether BBA03 might provide a competitive advantage that 
FIG 3
Immunoblot confirming the absence and restoration of BBA03 production in the ⌬A03 mutant and ⌬A03/A03 complemented strains. Antisera to BBA03 and FlaB were used to probe lysates of approximately 10 7 spirochetes. B. burgdorferi strains are identified above the lanes. Lysates from the A3⌬A1-7 mutant, which lacks the region of lp54 from bba01 to bba07, and strain B314, which lacks the entire lp54 plasmid, were used as negative controls for BBA03 production. spirochetes with mouse sera diluted 1:200. The number of mice infected by ⌬A03-infected nymphs was not significantly different from the number of mice fed on by wild-type-infected nymphs (P ϭ 0.214, as determined by Fisher's two-tailed exact probability test). c The ear, bladder, and tibiotarsal joint were cultured from all mice, for a total of three cultured tissues from each mouse. Mice positive for infection by serology were also positive by reisolation from all three tissues, and vice versa.
would not be observed by introducing the ⌬A03 mutant alone into a mammalian host. To address this possibility, we conducted two types of competitive assays: coinjecting a mixed inoculum of WT and ⌬A03 spirochetes into mice and challenging mice with ticks coinfected with both WT and ⌬A03 mutant spirochetes.
In vitro-grown WT and ⌬A03 mutant B. burgdorferi spirochetes were mixed at a combined inoculum of 5 ϫ 10 3 spirochetes (2.5 ϫ 10 3 spirochetes of each strain) and delivered by intradermal injection into 10 naïve mice. At 3 weeks postinjection, mice were euthanized and tissues were cultured in appropriate antibiotic selection medium to distinguish between B. burgdorferi strains. The ⌬A03 mutant was found to have successfully established infection and disseminated to distal tissues in 9 of the 10 mice (Table 6) . These data further demonstrate that the ⌬A03 mutant is able to establish mammalian infection by this route, even when coinjected with WT B. burgdorferi.
To investigate the requirement for BBA03 during tick transmission of a mixed infection, I. scapularis larvae were artificially infected with a culture containing equal proportions of WT and ⌬A03 mutant B. burgdorferi spirochetes. The coinfected larval ticks were fed to repletion, and a subset were individually ground and plated to confirm that the numbers of spirochetes of the two strains within the ticks were relatively equal. Ticks were allowed to molt to nymphs and were then fed on naïve mice at a dose of 5 ticks per mouse. At 7 days postfeeding, recovered fed nymphs were plated to enumerate the numbers of spirochetes of each B. burgdorferi strain within individual ticks. At 3 weeks postfeeding, mice were euthanized and tissues were cultured in appropriate antibiotic selection medium to distinguish between WT and ⌬A03 mutant B. burgdorferi spirochetes. Although the numbers of WT and ⌬A03 mutant spirochetes within the ticks were comparable (Fig. 4) , the ⌬A03 mutant was recovered from only 7 of 20 mice that were fed on by the coinfected nymphs, with 5 of those mice displaying reduced tissue colonization of the ⌬A03 mutant compared to the WT at this time point (Fig. 4) . This outcome was surprising considering the full infectivity of the ⌬A03 mutant transmitted by ticks infected with it alone (Tables 4 and 5 and Fig.  4, mouse 4) . In contrast, WT spirochetes were present in 19 of these mice, even when the mice were challenged with infected ticks carrying a small proportion of WT spirochetes (e.g., see Fig. 4 , mice 14 and 15). These data suggest that BBA03 may provide a competitive advantage for B. burgdorferi during tick-transmitted infection of the mammalian host.
Competition experiments were also done with ticks coinfected with the WT and the ⌬A03/A03 complemented strain to address whether the ⌬A03 mutant could successfully compete with wildtype B. burgdorferi when bba03 was restored. However, similar to what was seen when ticks were infected with ⌬A03/A03 alone, the complementing plasmid was consistently lost once the dually in- a Three infected nymphs were fed to repletion on each naïve mouse. At 7 days postfeeding, fed nymphs were individually crushed and plated to enumerate the number of viable spirochetes. The mean number of spirochetes per tick Ϯ the standard deviation was calculated from the total number of colonies obtained from all fed nymphs. Mean numbers of spirochetes were not significantly different between strains, as determined by one-way analysis of variance (ANOVA) (P ϭ 0.07). b Mouse infection was assessed initially by serology at 3 weeks postfeeding by immunoblot analysis with B. burgdorferi lysate, probing the total lysate from approximately 10 7 spirochetes with mouse sera diluted 1:200. As expected, the number of mice infected by ⌬A03 nymphs was not significantly different from the number of mice fed on by wild-type-or ⌬A03/A03-infected nymphs. c The ear, bladder, and tibiotarsal joint were cultured from all mice, for a total of three cultured tissues from each mouse. Mice positive for infection by serology were also positive by reisolation from all three tissues, and vice versa. d Although ticks were initially infected with the ⌬A03/A03 complemented strain, the pBSV2G-A03 plasmid had been lost from these spirochetes at the completion of nymphal feeding, rendering them ⌬A03 mutants. a Mice were injected with a mixed total inoculum of 5 ϫ 10 3 spirochetes (2.5 ϫ 10 3 WT spirochetes plus 2.5 ϫ 10 3 ⌬A03 spirochetes) by intradermal injection. Seroconversion was determined by immunoblotting with B. burgdorferi lysate at 3 weeks postinjection. b Mice were euthanized, and one ear, the bladder, and one joint were cultured in nonselective BSKII at 3 weeks postinjection. c The remaining ear and joint of euthanized mice were cultured in selective BSKII containing 50 g/ml streptomycin to allow growth of the ⌬A03 mutant only. fected ticks took a blood meal. On average, only 27% of the ⌬A03/ A03 complemented spirochetes within the coinfected ticks retained the pBSV2G-A03 shuttle vector at the time of tick drop-off. This resulted in transmission data similar to those seen with ticks coinfected with the WT and ⌬A03 mutant strains, where only the WT strain consistently established fully disseminated mammalian infection (data not shown). Spirochetes reisolated from mouse tissues in medium containing streptomycin (⌬A03 mutant) were also passed into medium containing gentamicin to investigate if any ⌬A03 mutant spirochetes retained the complementing plasmid. No viable spirochetes were ever recovered, suggesting that the pBSV2G-A03 plasmid had been lost completely by this time point. Localization and immunogenicity of BBA03. Since BBA03 is annotated as a putative outer membrane lipoprotein, we investigated the cellular localization of BBA03 by its accessibility on intact organisms to BBA03 antibodies and proteinase K degradation. Immunofluorescence assays using heat-fixed B. burgdorferi resulted in strong BBA03 staining under conditions in which FlaB antibodies did not penetrate the outer membrane (Fig. 5) .
Immunoblots of cell lysates incubated with various concentrations of proteinase K were probed with BBA03 antiserum as well as with OspA and FlaB monoclonal antibodies. Only minimal BBA03 digestion was seen, even with high concentrations of proteinase K (Fig. 6 ), suggesting that BBA03 may not be susceptible to proteinase K degradation, since the immunofluorescence assay indicated that BBA03 is surface exposed. To address this possibility, disrupted cells were also incubated with proteinase K, which resulted in complete BBA03 degradation at all proteinase K concentrations (Fig. 6 ). Taken together, the above results suggest that BBA03 is at least partially surface exposed, and the lack of strong BBA03 digestion by proteinase K may be due to inaccessibility of cleavage sites, requiring higher concentrations of proteinase K for digestion to occur.
Since BBA03 appears to be a surface-exposed outer membrane protein expressed at the time of transmission, the immune response to BBA03 was tested using sera obtained from mice that were infected with B. burgdorferi by tick bite. Immunoblot analyses demonstrated that 22 of 30 sera from infected mice recognized recombinant BBA03 (data not shown), indicating that BBA03 can exhibit an immune response during tick-transmitted infection. These results are consistent with those reported by Barbour et al. in which BBA03 appeared to be an antigenic protein that is recognized by most, but not all, infected hosts (2) .
Active immunization with BBA03. Following confirmation of an immunogenic response to BBA03 in infected mammalian hosts, we attempted to actively immunize mice with purified recombinant BBA03. Groups of mice were injected with either 50 g of purified recombinant BBA03 or PBS alone (control), boosted twice, and challenged by feeding three infected nymphs on each mouse. Nymphs were fed to repletion and plated immediately upon drop-off to determine the number of spirochetes within each tick, resulting in average loads of ϳ10 4 spirochetes per tick fed on control mice and 7 ϫ 10 3 spirochetes per tick fed on BBA03-immunized mice. These spirochete numbers were not sig- nificantly different by the two-tailed unpaired t test (P ϭ 0.34). All mice were tested by serology to confirm that they recognized both recombinant and native BBA03 by immunoblotting prior to tick challenge (data not shown). Following challenge by tick bite, 8 of 10 control mice (injected with PBS alone) were infected, and 14 of 24 mice immunized with BBA03 were infected (data not shown). These results suggest that although immunization with recombinant BBA03 may offer minor protection from B. burgdorferi infection by tick bite, this protection is not significant by Fisher's two-tailed exact probability test (P ϭ 0.43).
DISCUSSION
Borrelia burgdorferi is maintained in nature in an enzootic cycle between a tick vector and a mammalian host. B. burgdorferi adapts to these two very different environments through an alternating surface protein profile in order to appropriately cope with the challenges associated with each host. Several outer surface-associated proteins encoded on the lp54 plasmid have already been shown to be critical at specific times during the infectious cycle. Among these are the outer surface protein A (OspA), which is required for persistence within the tick (3, 31) ; the decorin binding proteins A and B (DbpA/B), which are important for dissemination in the mammal (5, 47, 49, 53) ; BBA52, which may play a significant role during transmission (23); and BBA64, which has been shown to be required for transmission from the tick vector to the mammalian host (16) . In this study, we investigated the requirement for the putative outer membrane protein BBA03 in establishing mammalian infection by tick bite. We targeted BBA03 for further investigation following our finding that B. burgdorferi mutants lacking the bba01-bba07 region of lp54 were attenuated in the ability to establish mammalian infection by tick bite. This finding was interesting given that infectious dose studies demonstrated that the A3⌬A1-7 mutant was fully competent at establishing mammalian infection by needle inoculation using both in vitro-and tick-derived spirochetes. This phenotype is also similar to that observed by Patton et al., where B. burgdorferi lacking bba64 was fully capable of infecting mice by needle inoculation but was unable to establish mammalian infection by tick bite, even though the bba64 mutant could effectively multiply and migrate to the salivary glands during the tick blood meal (33) .
BBA03 was chosen as the most likely candidate for this phenotype because of previous studies indicating that expression of this gene is upregulated during the tick blood meal (8, 23 ) and because inactivation of other genes in this region did not have a negative impact on the spirochete's ability to successfully complete the infectious cycle (4, 35, 36, 54, 55) . Our current findings indicate that BBA03 is a surface-exposed outer membrane lipoprotein that is upregulated during the tick blood meal. However, inactivation of bba03 and assessment of the ⌬A03 mutant throughout the infectious cycle indicated that BBA03 is not required by B. burgdorferi to establish mammalian infection by tick transmission. This result suggests that the phenotype observed with the A3⌬A1-7 mutant is not due solely to the absence of BBA03 and could possibly be a cumulative effect of deleting two or more of the genes in the bba01-bba07 region of lp54.
The bba03 gene is present in all B. burgdorferi strains whose genomes have been characterized fully (20, 32, 40, 51, 56) , with the exception of strain 297, which appears to be missing the bba01-bba03 region of lp54 (10) . Given that BBA03 is a surface-exposed protein expressed specifically at the time of transmission, it was surprising to find that it appeared to be dispensable for completion of the experimental infectious cycle. To further investigate a potential role for BBA03, we coinfected ticks with WT and ⌬A03 mutant spirochetes in order to more closely mimic the competitive environment of mixed infections that B. burgdorferi typically encounters in the natural infectious cycle. Consistent with the expression of bba03, the ⌬A03 mutant demonstrated a significant decrease in the ability to be transmitted and establish infection when coinfecting a tick with wild-type B. burgdorferi, suggesting that BBA03 plays a role during tick transmission that is manifested only when B. burgdorferi is in a mixed infection with other spirochetes within the tick. The discrete but critical point and circumstance during the infectious cycle at which BBA03 conveys a selectable advantage perhaps underlie the linkage on lp54 with other genes that play key roles during tick colonization and transmission.
Studies done with the A3⌬A1-7 mutant, which lacks bba03, may provide some insight into the function of BBA03 during tickmediated transmission. ID 50 experiments with the A3⌬A1-7 mutant demonstrated that none of the genes in the bba01-bba07 region are necessary for establishing mammalian infection by needle inoculation, even for spirochetes derived from partially fed ticks, which should closely mimic the number of spirochetes necessary for establishing infection by tick bite. In addition, salivary glands derived from partially fed nymphs did not contain a reduced number of the A3⌬A1-7 mutant spirochetes relative to the number of spirochetes in WT-infected ticks, suggesting that none of the bba01-bba07 genes encode proteins that are required for efficient migration to the salivary glands. Preliminary experiments investigating salivary gland migration in ticks coinfected with WT and ⌬A03 mutant spirochetes also confirmed that BBA03 does not appear to be required (data not shown). Similar to what Patton et al. reported for BBA64 (33), our results suggest that BBA03 provides a key function at the salivary gland-host interface when the mutant is cotransmitted with wild-type B. burgdorferi.
The inability to successfully complement the ⌬A03 mutant in vivo was disappointing, but the results provide further data demonstrating the competitive advantage that BBA03 confers and the point during the infectious cycle at which it functions. Coinfection experiments using the ⌬A03/A03 complemented strain indicated that the majority of the complemented ⌬A03 mutant spirochetes had lost the pBSV2G-A03 shuttle vector by the time of tick drop-off. Since the salivary gland migration data indicated that BBA03 is not required for efficient migration to the salivary glands, we believe that these spirochetes lost the shuttle vector prior to the point at which BBA03 is required in this competitive environment. Although rapid loss of the shuttle vector during spirochete replication in the tick midgut resulted in unsuccessful colonization of the host by the ⌬A03 mutant in the context of a mixed infection, it provides additional data illustrating the importance of BBA03 at this stage of the infectious cycle. In addition, it is important to note that the insert on the complementing shuttle vector included the region of lp54 from the end of bba01 to the beginning of bba04, resulting in duplication of bba02 in the ⌬A03/ A03 spirochetes. Due to uncertainty regarding the precise location of the 3= end of bba02 and the start of the bba03 promoter, we initially felt it wise to include a generous bba03 5=-flanking region to ensure that the entire bba03 promoter region was included. However, it is possible that the additional copy of bba02 contributed to the instability of the pBSV2G-A03 shuttle vector, although this instability could also have been due to the apparent overexpression of BBA03 from the shuttle vector (Fig. 3) .
The coinfection of Ixodes ticks with multiple B. burgdorferi strains as well as with other pathogenic and nonpathogenic microorganisms has been well documented (1, 19, 27, 50) , although few studies address the potential enhancing or alternating effects that cocolonization of the vector may have on the acquisition and transmission of an organism (27, 34) . To our knowledge, this is the first documented example of a B. burgdorferi gene product whose absence directly affects the ability of the spirochete to complete its infectious cycle in a competitive environment. With an increasing body of data addressing the occurrence of multiple genotypes of B. burgdorferi cohabiting Ixodes ticks (6, 11, 17, 24, 28) and the prevalence at which a specific genotype is associated with human infection (12, 26, 46) , continued investigation of how proteins such as BBA03 contribute to the spirochete's fitness in the natural infectious cycle will provide greater insight into the ecological and functional biology of this zoonotic pathogen.
